meglumine has been researched along with Ovarian Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assili, S; Gity, M; Haghighatkhah, H; Kazerooni, AF; Malek, M; Nabil, M; Parviz, S; Saligheh Rad, H; Torbati, L | 1 |
| Hricak, H; Stern, JL; Stevens, SK | 1 |
2 other study(ies) available for meglumine and Ovarian Diseases
| Article | Year |
|---|---|
Semiquantitative dynamic contrast-enhanced MRI for accurate classification of complex adnexal masses.
Topics: Adolescent; Adult; Aged; Algorithms; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Machine Learning; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Ovarian Diseases; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2017 |
Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Ovarian Diseases; Ovarian Neoplasms; Ovary; Pentetic Acid | 1991 |